Selling Mexican Cosmetics in the US: MoCRA Requirements for Mexican Brands

By Vincent Cruz

Mexico is one of America’s largest trading partners, with a big cosmetics manufacturing base and a land border that makes U.S. logistics look easy. That proximity is exactly the trap. Many Mexican brands assume that COFEPRIS registration, a USMCA trade lane, and a U.S. distributor add up to a paperwork-light entry into the American market. They do not. FDA’s MoCRA requirements apply to a facility in Mexico exactly as they apply to a facility on the other side of the world.

This guide is written for the Mexican brand owner planning U.S. sales: what MoCRA requires of you, where COFEPRIS and FDA rules diverge, and the specific mistakes that catch Mexican brands. For the full compliance picture, start with the MoCRA Compliance Guide for Cosmetic Brands.

The core rule: COFEPRIS registration does not transfer

Everything in this guide follows from one fact: FDA does not recognize COFEPRIS compliance as a substitute for U.S. compliance. Specifically:

  • Your COFEPRIS sanitary registration or notification means nothing to FDA. The U.S. has its own facility registration and product listing system, and every filing must be made there.
  • USMCA changes nothing. The trade agreement lowers tariffs and smooths customs. It does not harmonize cosmetics regulation, waive a single FDA filing, or give Mexican facilities any exemption that other foreign facilities do not get.
  • Your Mexican responsible party or sanitary license holder has no standing with FDA. MoCRA has its own “responsible person” concept (the manufacturer, packer, or distributor whose name appears on the label), and it is a different legal role.
  • Your COFEPRIS GMP inspections and certifications are useful evidence of good practice, but none of them satisfies a U.S. filing requirement.
  • Geography is irrelevant. A plant two hours from the border is a “foreign facility” to FDA in the same way a plant in Asia is. Same registration, same agent requirement, same listings.

Plan your U.S. launch as a full compliance project, not a formality attached to a shipment you already know how to send.

Step 1: Register your facility with FDA

If your products are manufactured or processed in Mexico (or anywhere outside the U.S.) for sale in America, the facility must register with FDA. Key points for Mexican brands:

  • You need an FEI number first. The FDA Establishment Identifier is required before registration can be filed. Request it from FDA by email; processing typically takes 7 to 10 business days. Run the free FEI check to see whether your facility already has one.
  • Registration is filed through Cosmetics Direct, FDA’s online portal, using Form FDA 5066. The step-by-step process is covered in Cosmetics Direct: How to Register Your Facility.
  • Registration renews every two years, based on your facility’s initial registration date, with automated reminders from FDA. See MoCRA Biennial Renewal Explained.
  • Using a contract manufacturer (maquilador) in Mexico? The facility that manufactures the product is the one that registers. If you outsource production, that manufacturer’s facility registers (and it needs its own U.S. agent). See Private Label Cosmetics: Who Registers Under MoCRA.

A common Mexican-brand mistake: assuming your U.S. importer or distributor is registered, so you are covered. You are not. The manufacturing facility registers in its own name; nobody else’s registration substitutes for it.

Step 2: Name a U.S. agent

Every foreign facility registering with FDA must designate a U.S. agent: a person or business physically present in the United States who serves as FDA’s official contact for the facility. This is not optional, and a Mexican address cannot fill the role.

The agent receives FDA correspondence, relays it to you, and is the contact FDA reaches out to with questions about your facility. One nuance matters for Mexican brands: your U.S. distributor or importer can serve as your agent only if they formally agree to the role and meet FDA’s requirements – an importing arrangement by itself does not make them your agent. Many brands use an independent agent instead, so the role survives if the distribution deal changes. Our own service is a flat $450 one-time onboarding plus $34.99 per month per facility; see MoCRA U.S. Agent Cost for how agent pricing generally works. For how to evaluate providers, see How to Choose a MoCRA U.S. Agent and Who Can Be a MoCRA U.S. Agent.

Step 3: List your products

Each cosmetic product sold in the U.S. must be listed with FDA through Cosmetics Direct (Form FDA 5067), filed by the responsible person. Listings include product and ingredient information and must be kept current with annual updates.

Note the Mexico difference: COFEPRIS notifications and registrations create a record in Mexico’s system only. The U.S. listing system is separate, in a different format, with different legal consequences – and the duty falls on the responsible person whose name is on the U.S. label, even when a distributor handles the border crossing. For how registration and listing differ, see Facility Registration vs Product Listing Explained. For how importer arrangements interact with these duties, see Cosmetic Importers and FDA Registration.

Step 4: Redo your labels for the U.S. market

Mexican labels are built to Mexico’s NOM-141 labeling standard, in Spanish. Almost none of that carries over. Your U.S. labels are a fresh design job:

Language. All required label information must be in English and must be prominent and conspicuous. A Spanish-only label that is fully compliant in Mexico is not compliant in the U.S. Bilingual English/Spanish labels are allowed and often smart for the U.S. market – but English is mandatory, not optional.

Ingredient declaration. Both markets use INCI-style nomenclature, so your ingredient list mostly transfers. But the U.S. requires ingredients in descending order of predominance with specific formatting rules, Spanish ingredient names must be rendered in their English INCI names, and FDA is developing fragrance allergen labeling regulations that will add new disclosure requirements.

Net quantity. U.S. consumer commodities must state net quantity in both U.S. customary and metric units, placed in a specific location on the principal display panel. Mexican labels showing metric only need updating.

Name and place of business. The label must show the name and place of business of the manufacturer, packer, or distributor. A Mexican address alone is acceptable only if the product is not misleading about origin; many Mexican brands add their U.S. distributor’s information.

Domestic contact for adverse events. MoCRA requires labels to carry a U.S. domestic contact – an address, phone number, or electronic contact – through which consumers can report adverse events. A Mexican contact alone does not satisfy this.

Identity statement. The common or usual name of the product must appear prominently, in English.

Warnings and directions. Certain product types require specific warning statements under U.S. rules. Products also regulated as drugs need Drug Facts labeling instead.

Claims review. Marketing claims written for the Mexican market can be drug claims in the U.S. Traditional and herbal positioning – “cura,” “trata,” anti-hair-loss, skin-lightening claims – needs re-evaluation under U.S. definitions before the product ships. See Is Your Product a Cosmetic or a Drug?.

For the detailed labeling changes MoCRA introduced, see MoCRA Labeling Changes.

The pitfalls that catch Mexican brands specifically

  • Assuming COFEPRIS registration transfers. It does not, in any respect. Separate filings, separate labels, separate agent.
  • Assuming USMCA or proximity lightens the load. Tariffs are a customs question; MoCRA is a regulatory one. The short truck ride changes nothing FDA asks of you.
  • Relying on the distributor or importer. Your U.S. partner may offer to “handle compliance,” and importers do have their own obligations – but they cannot register your Mexican facility, and their importer status does not erase your facility’s registration and U.S.-agent duties. Keep control of your own filings.
  • Shipping first, registering later. Because the border is close and shipments are fast, Mexican brands often start selling while “the paperwork is in progress.” FDA’s requirements apply to products already on the U.S. market; a fast supply chain just means non-compliant product reaches shelves faster.
  • Leaving the Spanish label as-is. A NOM-141 label fails U.S. rules on language, net quantity, and the adverse-event contact at minimum. Budget the label redesign as part of the launch, not an afterthought.
  • Small-business exemption confusion. The U.S. small-business exemption (Section 612 of the FD&C Act, 21 U.S.C. section 364h) is based on U.S. sales, not Mexican revenue, and it never exempts labeling, safety substantiation, or adverse event reporting. Check the exemption worksheet rather than assuming.
  • Forgetting the ongoing duties. Registration is not a one-time event: biennial renewal, annual listing updates, adverse event reporting within 15 business days for serious events, and records kept for 6 years. See MoCRA Adverse Event Reporting.

A realistic Mexico-to-US launch sequence

  1. Classify every product as cosmetic or drug for the U.S. market (re-do claims and ingredients, not just labels).
  2. Confirm whether you qualify for the small-business exemption; if not, proceed with full compliance.
  3. Request your facility’s FEI number (7 to 10 business days).
  4. Choose and appoint your U.S. agent.
  5. File facility registration via Cosmetics Direct.
  6. File product listings.
  7. Finalize U.S.-compliant (English) labels before the first shipment.
  8. Set up adverse event intake and record-keeping from day one.

For realistic timing on each step, see How Long Does MoCRA Facility Registration Take?.

FAQ

Do I need a U.S. agent if I sell through an American distributor?
Yes, if your products are manufactured outside the U.S. The foreign manufacturing facility must designate its own U.S. agent as part of facility registration. Your distributor cannot substitute for this unless it formally serves as the agent and meets FDA’s requirements.

Does my COFEPRIS registration count as a U.S. product listing?
No. The COFEPRIS system and the U.S. listing system are completely separate. You must list products with FDA through Cosmetics Direct regardless of COFEPRIS status.

Does USMCA make FDA registration easier for Mexican brands?
No. USMCA covers tariffs and customs procedures. FDA’s MoCRA facility registration, U.S. agent, and product listing requirements apply to Mexican facilities exactly as they apply to facilities anywhere else in the world.

Can my U.S. importer be my U.S. agent?
Possibly – if they formally agree to take on the role and meet FDA’s requirements (physically present in the U.S. and available as FDA’s contact). Simply importing your products does not make them your agent. Get any such arrangement in writing.

Are Mexican cosmetic labels acceptable in the US?
No, not as they stand. U.S. labels must be in English, state net quantity in U.S. customary and metric units, and carry a U.S. domestic contact for adverse-event reports, among other differences from the NOM-141 standard.

How long does the whole process take for a Mexican brand?
The FEI request alone takes 7 to 10 business days, and gathering registration details, appointing an agent, and finalizing labels adds more time. Plan for several weeks minimum from a standing start; see How Long Does MoCRA Facility Registration Take? for the full breakdown.


Next step: Mexican brand planning U.S. sales? Contact us for a straight assessment of what your products need, or run the free FEI check to confirm whether your facility already has an FDA Establishment Identifier.

This article is for educational purposes only and is not legal advice. US MoCRA Agent is a private service provider and is not affiliated with or endorsed by the FDA.

Scroll to Top